Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review

Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review

Over the previous twenty years, tumor necrosis factor-α (TNF-α) inhibitors grew to become probably the most necessary medicine within the therapy of sufferers with psoriatic arthritis. Sadly, a few of the sufferers exhibit undesirable unintended effects of the therapy. We describe a affected person with psoriasis, psoriatic arthritis and uveitis who was handled with adalimumab…

Read More